Skip to content

Registration of Skin-Temperatures and Sleep-Wake Behaviour

Registration of Skin-Temperatures and Sleep-Wake Behaviour in the Daily Life of Women With Vasospasm in Comparison to Controls

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00319371
Enrollment
40
Registered
2006-04-27
Start date
2005-11-30
Completion date
2006-06-30
Last updated
2008-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vasospastic Syndrome

Keywords

vasospasm, circadian, sleep-disorders

Brief summary

We study the skin-temperature (skin temperature measurement on different skin regions) and circadian rest-activity cycles (wrist activity monitoring) of 40 women in their daily life. This project will provide further information at which circadian phase vasospasms occur in daily routine life (one week recordings). Special interest lays on the time before sleep. The attained results could be used to establish a therapy with few side effects for people with difficulties initiating sleep because of vasospasm.

Detailed description

We study the skin-temperature and circadian rest-activity cycles of 40 women in their daily life. 20 women with vasospasm and difficulties of initiating sleep and 20 women without vasospasm and no difficulties of initiating sleep. Women without contraceptives will be examined in the luteal phase (i.e. in the two weeks before menstruation). The ambulant registry will be done continuously during one week with so called i-Buttons (IButtonTM, Maxim, USA). These will be fixed to various parts of the body (i.e. wrist, ankle, …) with Fixomull, a medical bond. Also the subjects have to wear a instrument for registration activity, the so called Actiwatch (Cambridge, UK). The data that will be gained from these instruments, shall help us to objectify sleep-latency and sleep-fragmentation (sleeping-through). Furthermore, the subjects obtain a sleep-and activity-dairy, that has to be filled before and after sleeping. At one day, that the proband can choose, saliva samples have to be taken by the subjects themselves. In the saliva, the concentration of melatonin will be qualified. The attained results could be used to establish a therapy with few side effects for people with difficulties of initiating sleep because of vasospasm.

Interventions

None listed

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects have to show a vasospasm and difficulties of initiating sleep (screening with questionnaires and interview) * Controls have to show no vasospasm and no difficulties of initiating sleep (screening with questionnaires and interview)

Exclusion criteria

* bad health or unhealthy conditions * allergies (i.e. nickel) * medication * BMI\<18 * migraine * delayed sleep phase syndrome * advanced sleep phase syndrome * alcohol- or drug problems * smokers * blood donation in last three months before study * participation at an other clinical study in last three months before study * shift work in last three months before study * long-distance flight (\> 2 time zones) in last month before study

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026